Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 1250
Summary
- Conditions
- Venous Thromboembolism
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02558465
- Collaborators
- Janssen Research & Development, LLC
- Investigators
- Study Director: Bayer Study Director Bayer